Semiquantitative assessment of breath hydrogen testing. 2013

Jacqueline S Barrett, and Udaya Kalubovila, and Peter M Irving, and Peter R Gibson
Monash University, Eastern Health Clinical School, Box Hill, Victoria, Australia.

OBJECTIVE A major use of breath hydrogen testing is to assess absorptive capacity for sugars to assist dietary design for management of gut symptoms. Qualitative reporting takes no account of the vigor of hydrogen response and provides little insight into degrees of malabsorption. This study aimed to describe a semiquantitative reporting method and to compare results with those reported qualitatively. METHODS In consecutive Caucasian patients with Crohn's disease (n = 87), ulcerative colitis (59), functional gastrointestinal disorders (FGID) (162), and healthy controls (76), area under the curve was calculated for lactulose (15 g). This was compared with that for lactose (50 g) and fructose (35 g). Degree of malabsorption was categorized into arbitrary groups. RESULTS Semiquantitative results for ≥ 30% (designated "convincing") malabsorption was most similar to those using a qualitative cutoff value of 20 ppm, but in 38% and 21% of patients, the classification of malabsorption (nil or clinically significant) changed for fructose and lactose, respectively. Using a cutoff of 10 ppm, 49% and 5% were classified differently. Crohn's disease had a higher prevalence (42%) of convincing fructose malabsorption than controls (24%) or patients with FGID (33%) (P < 0.02). Highest prevalence of convincing lactose malabsorption (38%) was in ulcerative colitis, greater than controls (18%) and FGID (18%) (P < 0.02). CONCLUSIONS Semiquantitative assessment provides different results with different clinical implications in more than one third of patients, but disease-related alterations in prevalence are similar to those defined qualitatively. This method may be preferable because it lessens the confounding influence of the vigor of the hydrogen response.

UI MeSH Term Description Entries
D007785 Lactose A disaccharide of GLUCOSE and GALACTOSE in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry. Anhydrous Lactose,Lactose, Anhydrous
D007787 Lactose Intolerance The condition resulting from the absence or deficiency of LACTASE in the MUCOSA cells of the GASTROINTESTINAL TRACT, and the inability to break down LACTOSE in milk for ABSORPTION. Bacterial fermentation of the unabsorbed lactose leads to symptoms that range from a mild indigestion (DYSPEPSIA) to severe DIARRHEA. Lactose intolerance may be an inborn error or acquired. Lactose Malabsorption,Alactasia,Dairy Product Intolerance,Hypolactasia,Milk Sugar Intolerance,Intolerance, Lactose,Malabsorption, Lactose
D007792 Lactulose A synthetic disaccharide used in the treatment of constipation and hepatic encephalopathy. It has also been used in the diagnosis of gastrointestinal disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p887) Amivalex,Duphalac,Normase
D008286 Malabsorption Syndromes General term for a group of MALNUTRITION syndromes caused by failure of normal INTESTINAL ABSORPTION of nutrients. Malabsorption Syndrome,Syndrome, Malabsorption,Syndromes, Malabsorption
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001944 Breath Tests Any tests done on exhaled air. Breathalyzer Tests,Breath Test,Breathalyzer Test,Test, Breath,Test, Breathalyzer,Tests, Breath,Tests, Breathalyzer
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D003424 Crohn Disease A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients. Colitis, Granulomatous,Enteritis, Granulomatous,Enteritis, Regional,Ileitis, Regional,Ileitis, Terminal,Ileocolitis,Crohn's Disease,Crohn's Enteritis,Inflammatory Bowel Disease 1,Regional Enteritis,Crohns Disease,Granulomatous Colitis,Granulomatous Enteritis,Regional Ileitides,Regional Ileitis,Terminal Ileitis
D005260 Female Females

Related Publications

Jacqueline S Barrett, and Udaya Kalubovila, and Peter M Irving, and Peter R Gibson
August 2009, Research in veterinary science,
Jacqueline S Barrett, and Udaya Kalubovila, and Peter M Irving, and Peter R Gibson
March 2017, Journal of gastroenterology and hepatology,
Jacqueline S Barrett, and Udaya Kalubovila, and Peter M Irving, and Peter R Gibson
January 1988, Journal of pediatric gastroenterology and nutrition,
Jacqueline S Barrett, and Udaya Kalubovila, and Peter M Irving, and Peter R Gibson
March 2018, Journal of clinical gastroenterology,
Jacqueline S Barrett, and Udaya Kalubovila, and Peter M Irving, and Peter R Gibson
June 2000, Diabetes care,
Jacqueline S Barrett, and Udaya Kalubovila, and Peter M Irving, and Peter R Gibson
August 1990, Gastroenterology,
Jacqueline S Barrett, and Udaya Kalubovila, and Peter M Irving, and Peter R Gibson
January 2021, Scientific reports,
Jacqueline S Barrett, and Udaya Kalubovila, and Peter M Irving, and Peter R Gibson
September 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
Jacqueline S Barrett, and Udaya Kalubovila, and Peter M Irving, and Peter R Gibson
October 1988, Gastroenterology,
Jacqueline S Barrett, and Udaya Kalubovila, and Peter M Irving, and Peter R Gibson
June 1992, The American journal of physiology,
Copied contents to your clipboard!